We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New DNA Testing Method Offers Faster and More Accurate Pathogen Identification

By LabMedica International staff writers
Posted on 05 Jun 2024
Print article
Image: The new method offers faster, more accurate pathogen identification, even in complex DNA sequences (Photo courtesy of 123RF)
Image: The new method offers faster, more accurate pathogen identification, even in complex DNA sequences (Photo courtesy of 123RF)

The Polymerase Chain Reaction (PCR) is widely regarded as the definitive method for target DNA sequence amplification, testing, and analysis. In this traditional PCR process, the DNA sample undergoes heating to separate into single strands, which then serve as templates for synthesizing new DNA strands through enzymatic action. Despite its effectiveness, this method can be cumbersome, slow, and costly. Now, researchers have introduced an alternative DNA testing method that could potentially replace traditional PCR, paving the way for broader applications in medical diagnostics.

Developed at Case Western Reserve University (Cleveland, OH, USA), this new technique or reaction is named AMPLON (Amplifying DNA with Multiarm Priming and Looping Optimization of Nucleic Acid). It enables comparison of DNA from diseased cells with that from healthy ones, enhancing understanding of disease progression and treatment approaches. AMPLON uses multiple extensions along the DNA strand, significantly enhancing the speed and accuracy of DNA synthesis at a constant temperature. This simplified method avoids the thermal stress typically imposed on materials by traditional PCR's fluctuating temperatures.

Furthermore, AMPLON offers a more organized and practical amplification method, particularly beneficial in environments where maintaining precise temperature control is difficult. The innovative design of its multi-armed DNA primers turns the limitations associated with enzymatic reactions into advantages, increasing the efficiency of the amplification process and ensuring consistent results. This new technique holds promise for transforming molecular analysis and clinical diagnostics across various fields, including infectious disease diagnostics, personalized medicine, and environmental monitoring. 

“We’ve developed a new method of DNA amplification that does not require bulky lab-bound equipment but can be conducted in one step and in diverse settings. More significantly, our approach does not weaken enzymes like the PCR method,” said Mohamed S. Draz, an assistant professor at Case Western Reserve's School of Medicine and the principal investigator of the study, which was recently published in the journal Advanced Materials. “We’ve been able to enhance amplification and reduce amplification time by 50%. Our approach has the potential to dramatically change the way nucleic acid amplification is performed, providing instead a portable, reliable and cost-effective solution for applications, ranging from point-of-care diagnostics to field-based research.” 

Related Links:
Case Western Reserve University

New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Preterm Delivery Test
PREMAQUICK
New
Calprotectin One Step Card Test
CerTest Calprotectin

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
A schematic of the 3D MM imaging experimental setup used in the studies of blood films (Photo courtesy of Ushenko, A.G., et al.; doi.org/10.1038/s41598-024-63816-z)

Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis

A quicker, cheaper, and less painful cancer detection technique developed using light has the potential to revolutionize cancer diagnosis, early detection, and monitoring. Researchers at Aston Institute... Read more

Industry

view channel
Image: The QIAstat-Dx IVD panel for neurodegenerative applications will be integrated with the QIAstat-Dx multiplex testing platform (Photo courtesy of QIAGEN)

Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications

QIAGEN N.V. (Venlo, the Netherlands) has entered into a collaboration with Eli Lilly and Company (Indianapolis, IN, USA) to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) to detect APOE genotypes.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.